Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial: Rationale and design

American Heart Journal

Volumn 157, Issue 3, 2009, Pages

  Myles, Paul S ^a,b,c   Leslie, Kate ^d   Peyton, Philip ^e   Paech, Michael ^f   Forbes, Andrew ^b   Chan, Matthew T V ^g   Sessler, Daniel ^h   Devereaux, Philip J ⁱ   Silbert, Brendan S ^j   Jamrozik, Konrad ^k   Beattie, Scott ^l   Badner, Neal ^m   Tomlinson, James ^a,b   Wallace, Sophia ^a  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Monash and Adelaide Universities   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e AUSTIN HOSPITAL   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j ST VINCENT S HOSPITAL   (Australia)

^k UNIVERSITY OF ADELAIDE   (Australia)

^l UNIVERSITY HEALTH NETWORK   (Canada)

^m UNIVERSITY OF WESTERN ONTARIO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; DIGOXIN; DIURETIC AGENT; DROPERIDOL; HALOPERIDOL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE; NITROUS OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; SEROTONIN 3 ANTAGONIST; TICLOPIDINE; WARFARIN;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FEVER; HEART ARREST; HEART INFARCTION; HEART SURGERY; HUMAN; HYPERTENSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; NAUSEA AND VOMITING; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME; VASCULAR SURGERY; VOMITING; WOUND INFECTION;

EID: 60649102895     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.11.015     Document Type: Article

References (30)

1. Weiser T.G., Regenbogen S.E., Thompson K.D., et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 372 (2008) 139-144
2. Mangano D.T. Perioperative cardiac morbidity. Anesthesiology 72 (1990) 153-184
3. Devereaux P.J., Goldman L., Cook D.J., et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 173 (2005) 627-634
4. Fleisher L.A., Corbett W., Berry C., et al. Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients. J Cardiothorac Vasc Anesth 18 (2004) 7-13
5. Devereaux P.J., Yang H., Yusuf S., et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371 (2008) 1839-1847
6. Mangano D.T., and Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 333 (1995) 1750-1756
7. Myles P.S., Leslie K., Silbert B., et al. A review of the risks and benefits of nitrous oxide in current anaesthetic practice. Anaesth Intensive Care 32 (2004) 165-172
8. Nunn J.F. Clinical aspects of the interaction between nitrous oxide and vitamin B12. Br J Anaesth 59 (1987) 3-13
9. Maze M., and Fujinaga M. Recent advances in understanding the actions and toxicity of nitrous oxide. Anaesthesia 55 (2000) 311-314
10. Amos R.J., Amess J.A., Hinds C.J., et al. Incidence and pathogenesis of acute megaloblastic bone marrow change in patients receiving intensive care. Lancet 2 (1982) 835-838
11. Badner N.H., Beattie W.S., Freeman D., et al. Nitrous oxide-induced elevated homocysteine concentrations are associated with increased myocardial ischemia in patients undergoing carotid endarterectomy. Anesth Analg 91 (2000) 1073-1079
12. Myles P.S., Chan M.T.V., Leslie K., et al. Effect of nitrous oxide on plasma homocysteine and folate in patients undergoing major surgery. Br J Anaesth 100 (2008) 780-786
13. Myles P.S., Chan M.T.V., Kaye D.M., et al. Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function. Anesthesiology 109 (2008) 657-663
14. Hynes M.D. Catecholamine mechanisms in the stimulation of mouse locomotor activity by nitrous oxide and morphine. Eur J Pharmacol 90 (1983) 109-114
15. Myles P.S., Leslie K., Chan M.T.V., et al. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology 107 (2007) 221-231
16. Ermens A.A., Refsum H., Rupreht J., et al. Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine. Clin Pharmacol Ther 49 (1991) 385-393
17. Mayer E.L., Jacobsen D.W., and Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 27 (1996) 517-527
18. Bellamy M.F., McDowell I.F., Ramsey M.W., et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 98 (1998) 1848-1852
19. Chambers J.C., McGregor A., Jean-Marie J., et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 99 (1999) 1156-1160
20. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325 (2002) 1202-1209
21. Fleischmann E., Lenhardt R., Kurz A., et al. Nitrous oxide and risk of surgical wound infection: a randomised trial. Lancet 366 (2005) 1101-1107
22. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
23. Tunis S.R., Stryer D.B., and Clancy C.M. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290 (2003) 1624-1632
24. Raby K.E., Goldman L., Creager M.A., et al. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med 321 (1989) 1296-1300
25. Kapoor A.S., Kanji H., Buckingham J., et al. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 333 (2006) 1149-1156
26. Frank S.M., Fleisher L.A., Breslow M.J., et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. JAMA 277 (1997) 1127-1134
27. Rodgers A., Walker N., Schug S., et al. Reduction of post-operative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 321 (2000) 1493-1497
28. Beattie W.S., Badner N.H., and Choi P.T. Meta-analysis demonstrates statistically significant reduction in postoperative myocardial infarction with the use of thoracic epidural analgesia. Anesth Analg 97 (2003) 919-920
29. Wijeysundera D.N., Beattie W.S., Rao V., et al. Calcium antagonists are associated with reduced mortality after cardiac surgery: a propensity analysis. J Thorac Cardiovasc Surg 127 (2004) 755-762
30. DeMets D.L., Pocock S.J., and Julian D.G. The agonising negative trend in monitoring of clinical trials. Lancet 354 (1999) 1983-1988